Anti-inflammatory effects of low-level laser therapy on human periodontal ligament cells: in vitro study
- 305 Downloads
Periodontal disease is a chronic inflammatory disease that is commonly treated with surgical and nonsurgical techniques. However, both approaches have limitations. Low-level laser therapy (LLLT) has been widely applied in reducing inflammatory reactions, and research indicates that LLLT induces an anti-inflammatory effect that may enhance periodontal disease therapy. The purpose of this study was to investigate the anti-inflammatory effect of LLLT on human periodontal ligament cells (hPDLCs) in an inflammatory environment and aimed to determine the possible mechanism of action. Cells were cultured and treated with or without lipopolysaccharide (LPS) from Porphryromonas gingivalis or Escherichia coli, followed by irradiation with a gallium-aluminum-arsenide (GaAlAs) laser (660 nm) at an energy density of 8 J/cm2. Quantitative real-time polymerase chain reactions were used to assess the expression of pro-inflammatory genes, including tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, and IL-8. The dual-luciferase reporter assay was used to examine nuclear factor-κB (NF-κB) transcriptional activity. An enzyme-linked immunosorbent assay was used to monitor the concentration of intracellular cyclic adenosine monophosphate (cAMP). Both LPS treatments significantly induced the mRNA expression of pro-inflammatory cytokines. However, LLLT inhibited the LPS-induced pro-inflammatory cytokine expression and elevated intracellular levels of cAMP. The LLLT inhibitory effect may function by downregulating NF-κB transcriptional activity and by increasing the intracellular levels of cAMP. LLLT might inhibit LPS-induced inflammation in hPDLCs through cAMP/NF-κB regulation. These results should be further studied to improve periodontal therapy.
KeywordsLow-level light therapy Cyclic AMP NF-kappa B Cytokines Interleukins Lipopolysaccharides
Periodontal disease is a common and complex inflammatory disease that results in progressive destruction of the tooth-supporting soft and hard tissues of the periodontium . The resulting damage affects the alveolar bone as well as the periodontal ligament (PDL). Although surgical therapies such as open flap surgery and osseous surgery and nonsurgical therapies such as standard oral hygiene procedure and sustained local delivery antimicrobial agents are helpful in controlling this disease, both treatment options have limitations. Patients with deep pockets or furcation involvement did not respond well to nonsurgical therapy, and surgical therapy was more invasive and risky when treating patients with systemic problems [2, 3].
It has been reported that one of the functions of PDL cells is to respond to environmental stresses, such as inflammatory cytokines and pathogens [4, 5]. Sun et al. reported that lipopolysaccharide (LPS) exposure induces the expression of cytokines in PDL cells, including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-8 . Inflammatory cells as well as PDL cells regulate the periodontitis process [4, 5, 6], although the exact roles of different cell types require further clarification.
LPS is a macromolecule with a lipid element (lipid A) and a polysaccharide element . LPS is located on the exterior membrane of gram-negative bacteria and stimulates powerful immune responses in animals. Indeed, the immune systems of animals have evolved to recognize LPS via toll-like receptors (TLRs) . TLRs are a class of transmembrane proteins that contain numerous leucine-rich repeats and are composed of globular intracellular regions and extracellular domains . Eleven different TLRs in humans have been identified . Among them, TLR2 and 4 function as the principal innate sensors for the virulent factors of periodontopathic bacteria [11, 12]. LPS binding to TLR 2 and 4 triggers activation of the nuclear factor kappa B (NF-κB) signaling cascade, inducing the secretion of pro-inflammatory cytokines such as TNF-α and IL-1β . Alterations to the number, position, and length of the acyl groups or monosaccharide groups in lipid A will result in alterations in the biologic effects . Based on these mechanisms, LPS from different bacterial species may trigger different types of immune responses.
In the past few decades, low-level laser therapy (LLLT) has been widely employed in the treatment of wound healing, musculoskeletal pain, and chronic and acute inflammation [15, 16]. Studies have identified the benefits of using LLLT [17, 18]. For example, Bortone et al. reported that LLLT induced an anti-inflammatory effect through the regulation of pro-inflammatory mRNAs . Obradovic et al. reported that low-level lasers have shown efficacy in reducing inflammation of periodontitis in patients with diabetes mellitus . However, the precise mechanism by which LLLT regulates periodontal inflammation remains unknown.
Cyclic adenosine monophosphate (cAMP) functions as an important second messenger in many cell physiological processes, such as cell differentiation, proliferation, apoptosis, and inflammation . cAMP is formed by the activation of adenylyl cyclase and is converted from adenosine triphosphate . Also, cAMP was recently implicated in pro-inflammatory processes as it was shown to not only serve as a modulator of immune function but also as a regulator in response to LLLT signaling . However, the potential relationship between cAMP and LLLT in affecting the LPS-induced inflammatory response in human periodontal ligament cells (hPDLCs) has not been investigated.
In this study, we investigated the anti-inflammatory effects of LLLT on hPDLCs that were exposed to LPS from Porphryromonas gingivalis (P. gingivalis) or Escherichia coli (E. coli) and aimed to determine the possible mechanism of action.
Materials and methods
The procedure for hPDL cell preparation was according to a modification of the method reported by D’Errico et al. . Briefly, hPDL tissues were collected from the middle third of periodontally healthy and non-carious third molar roots extracted from healthy volunteers (20 to 40 years of age) during the course of orthodontic treatment. Periodontal ligament tissue was scraped from third molars, enzymatically digested by 2 mg/mL collagenase and 0.25% trypsin for 1 h at 37 °C. The cells were harvested by centrifugation for 10 min at 500×g. The supernatant was carefully aspirated, and cells were washed twice with Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum. The cells were expanded with DMEM supplemented with 10% fetal bovine serum, 100 mg/mL penicillin-G, 100 mg/mL kanamycin sulfate, and 0.3 mg/mL amphotericin B. The cultures were kept at 37 °C in a humidified incubator in the presence of 95% air and 5% CO2. The medium was changed every other day. The cells were used at passages 3 to 9.
Chemical inhibitor and reagent treatments
LPS from E. coli and P. gingivalis was dissolved in 1× phosphate-buffered saline at a final concentration of 10 mg/mL and stored at 4 °C. The hPDLCs were treated with different concentrations of LPS (0, 10, 20, 50, and 100 μg/mL) from P. gingivalis and E. coli freshly diluted in culture medium. The adenylyl cyclase inhibitor SQ22536 (Sigma-Aldrich, St. Louis, MO, USA) was used to block the activity of adenylyl cyclase. SQ22536 was dissolved in dimethyl sulfoxide (DMSO), and the cells were treated with a dose of 100 μmol/L. Forskolin (50 μmol/L, Sigma-Aldrich, St. Louis, MO, USA), an adenylyl cyclase activator, was dissolved in DMSO.
Low-level laser therapy
A gallium-aluminum-arsenide red laser with flat top beam profile (wavelength 660 nm diode laser, Transverse Industries Co., Ltd., Taipei, Taiwan) was used as the laser source. The output of the laser device was 70 mW. The distance between the bottom of the culture plate and the laser source was 3 cm, and the irradiated area was 3.8 cm2. The cells were irradiated once for 528 s in a continuous mode and received 8 J/cm2 of laser energy density in total. All irradiation experiments were performed on a clean bench at room temperature. The control groups were processed under the same conditions, except without laser irradiation.
An MTT assay (3-[4, 5- dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide) was used to determine cell viability. The hPDLCs were seeded onto a 96-well plate. After exposure to LPS from P. gingivalis and E. coli for 24 h, the cells were incubated with 5 mg/mL MTT for 4 h. The reactions were measured using an enzyme-linked immunosorbent assay (ELISA) reader at 595 nm.
Lactate dehydrogenase leakage
Lactate dehydrogenase (LDH) leakage was measured to quantify cytotoxicity with a Cytotoxicity Detection kit. The hPDLCs were seeded onto a 96-well plate and cultured with different concentrations of LPS from P. gingivalis and E. coli for 24 h. The LDH leakage was calculated according to the manufacturer’s guidelines. The absorbance was measured with an ELISA reader at 490 nm.
Real-time reverse transcription-polymerase chain reaction (RT-PCR)
Intracellular cyclic adenosine monophosphate levels
ELISA kits for the detection of cAMP were obtained from Enzo (Farmingdale, NY, USA). All of the procedures were based on the manufacturer’s instructions, and the optical density was measured at a wavelength of 405 nm.
We cultured 2 × 104 hPDLCs in a 48-well plate and co-transfected the cells with the pGL 4.32 [luc2P/NF-κB-RE/Hygro] vector (250 ng) and pTK-Renilla vector (50 ng) using Lipofectamine 2000 (Thermo Fisher Scientific, Waltham, MA, USA). The transfection procedure was performed according to the manufacturer’s instructions. Twenty-four hours after transfection, the cells were treated with LPS, LLLT, and SQ22536 for an additional 6 h. The luciferase activity was measured using a dual-luciferase reporter assay system (Promega, Madison, WI, USA) with an Anthos Lucy3 microplate luminometer (AnthosLabtec Instruments, Austria).
All the data were collected from three to four independent experiments. Data were analyzed with the statistical software SPSS/Win version 17.0 and expressed as the mean ± standard deviation. For statistical analysis, normality was first tested using the Shapiro-Wilk test. For normally distributed data, one-way analysis of variance was used to test for statistical differences followed by the post hoc Tukey’s test. If the data failed the normality test, the nonparametric Kruskall-Wallis one-way analysis of variance was used to test for statistical differences with Dunn’s multiple comparison test. A p value of 0.05 was considered statistically significant.
The viability and cytotoxicty of LPS-challenged hPDLCs
The expression patterns of inflammatory cytokines in LPS-challenged hPDLCs
The anti-inflammation effect of LLLT on hPDLCs
To elucidate whether LLLT inhibited inflammatory cytokine mRNA expression by regulating cAMP, we treated hPDLCs with SQ22536, a pharmacological inhibitor of cAMP, and then treated with LPS and LLLT. In this group, the level of pro-inflammatory cytokine mRNA expression was not reduced by LLLT (Fig. 3).
The hPDLCs are human fibroblasts with multifunctional tissue that provide physical, formative and remodeling, nutritional, and sensory functions . In the present study, the hPDLCs were treated with different concentrations of LPS from P. gingivalis or E. coli. Our data showed that LPS from both P. gingivalis and E. coli induced pro-inflammatory cytokine (IL-1β, TNF-α, IL-6, IL-8) mRNA expressions in a dose-dependent manner. However, P. gingivalis-treated cells responded in a dose-dependent manner at lower doses when compared to E. coli-treated cells (Fig. 2). The different levels of induced inflammation from the two sources may be attributed to molecular differences in the lipid components. The lipid A from P. gingivalis LPS is a monophosphate type lacking a phosphate group in the 4′ position that does not contain a tetradecanoic acid, but rather long-chain fatty acids made up of only acyloxyl groups . It is believed that LPS from P. gingivalis is recognized mainly by TLR2, while LPS from E. coli is recognized mainly by TLR4 [23, 24, 25, 26]. Uehara et al. also reported that human gingival fibroblasts showed more robust mRNA expression of pro-inflammatory cytokines following TLR2 ligation (Mycoplasma-type diacyl lipopeptide) compared to TLR4 ligation (E. coli-type lipid A) . These results indicate that different sources of LPS might induce inflammation through different mechanisms.
In recent decades, many studies have shown that LLLT reduces inflammatory reactions both in vitro and in vivo. Correa et al. induced periodontitis in mice with LPS and found that LLLT (GaAs laser, 904 nm) diminished inflammatory cell migration in a dose-dependent manner, with an energy dose of 3 J/cm2 identified as the most effective dose . Pires et al. reported a model of collagenase-induced tendinitis and demonstrated that LLLT (780 nm), at an energy dose of 7.7 J/cm2, suppressed the expression of IL-6 . Boschi et al. reported that LLLT (InGaAlP laser, 660 nm) significantly reduced the expression of IL-6 and TNF-α . According to previous studies conducted in our lab , LLLT (GaAlAs laser, 660 nm) showed the most effective suppression of inflammation at the optimal dose of 8 J/cm2, which was used in this study. In the current study, we noted that LPS-challenged hPDLCs showed similar results to the aforementioned studies, suggesting that LLLT significantly suppressed the mRNA expression of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-8), leading us to conclude that LLLT has an anti-inflammatory effect in hPDLCs (Fig. 3). In addition, we noticed that the anti-inflammatory effect of LLLT was neutralized when the cAMP inhibitor SQ22536 was used (Fig. 3). We also observed that the level of cAMP from hPDLCs was elevated by both forskolin (cAMP promoter) and LLLT but decreased when SQ22536 (cAMP inhibitor) was added (Fig. 4), consistent with previous study that the level of cAMP increased by approximately 3- to 4-fold following LLLT treatment of human adipose-derived stem cells . This finding suggests that LLLT can act to stimulate the level of cAMP. Other studies have shown that the elevation of intracellular cAMP levels inhibited the transcriptional activity of NF-κB, which is a crucial transcription factor in the regulation of inflammation [32, 33]. Possible mechanisms that regulate of NF-κB activity include the ability of cAMP to manage IκB degradation and IKK activity as well as to change the composition of NF-κB dimers and thereby block transcription . Indeed, we observed that LLLT significantly inhibited the transcriptional activity of NF-κB in our previous study of LPS-stimulated human adipose-derived stem cells . In the present study, we treated LPS-stimulated hPDLCs with LLLT and the adenylyl cyclase inhibitor SQ22536 and observed that the inhibitory effect of LLLT on NF-κB transcriptional activity was significantly reduced (Fig. 5). Aimbire et al.  also reported results similar to ours, showing that a low-level laser (660 nm) at an energy dose of 7.5 J/cm2 inhibited NF-κB transcriptional activity and further reduced apoptotic gene expression.
Exploring LLLT’s role in regulating the induction of pro-inflammatory cytokine in periodontal pathology is important as it may lead to novel therapeutic approaches for periodontitis. This study has demonstrated that LLLT inhibits inflammation, induced by LPS from E. coli and P. gingivalis, through the cAMP/NF-ĸB signaling pathway in hPDLCs. Future research into the detailed regulation of LLLT on cAMP may be of great value in improving periodontal therapy.
Compliance with ethical standards
This study was independently reviewed and approved by the human subjects ethics board of Kaohsiung Medical University and was conducted in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
This study was funded by the Ministry of Science and Technology of Taiwan (MOST-104-2314-B-037-059-) and Kaohsiung Medical University Aim for the Top Universities Grants (KMU-TP103B08 and KMU-TP104B11).
Conflict of interest
The authors declare that they have no conflict of interest.
- 7.Simpson BW, May JM, Sherman DJ, Kahne D, Ruiz N (2015) Lipopolysaccharide transport to the cell surface: biosynthesis and extraction from the inner membrane. Philos Trans R Soc Lond B Biol Sci 370(1679)Google Scholar
- 29.Pires D, Xavier M, Araujo T, Silva JA Jr, Aimbire F, Albertini R (2011) Low-level laser therapy (LLLT; 780 nm) acts differently on mRNA expression of anti- and pro-inflammatory mediators in an experimental model of collagenase-induced tendinitis in rat. Lasers Med Sci 26(1):85–94CrossRefPubMedGoogle Scholar
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.